Latest press releases
VivoMedica’s DrugPrint could save drug recall casualties
14/02/2008
"DrugPrint is able to offer stem cell companies an opportunity to realise the potential of their technology,” said Mr Leyland... Tina Tan of Clinica finds out from UK medical device company VivoMedica
>> more infoUpdate on PathScore and DrugPrint
08/10/2007
Progress with the development of PathScore and DrugPrintTM has attracted positive feedback from potential partners and commercialisation discussions and are now actively being pursued.... >> Download Word Document
Proposed Name change
05/10/2007
Zi Medical (AIM: ZIM), the medical devices company, announces that at the Company’s Annual General Meeting held today, all the resolutions were duly passed, including a resolution to change the Company’s name to VivoMedica plc (AIM:VVM)... >> Download Word Document
Revised notice of Annual General Meeting and Name Change
12/09/2007
Notice of AGM
12/09/2007
Zi Medical (AIM: ZIM), the medical devices company, announces that it has today sent a circular to shareholders giving notice of its Revised Annual General Meeting (AGM), the date and time of which remains unchanged, at 11.00 am on 4th October 2007... >> Download pdf
Result of EGM
3/09/2007
The Company is pleased to announce that at the extraordinary general meeting held earlier today, the ordinary resolution was duly passed. As a result of the Resolution being passed, the Company is to dispose of the Infusion Business. Completion is expected to take place later today. >> Download Word Document
Directorate Resignation
3/09/2007
The Company announces that following the passing of the EGM resolutions earlier today, as previously announced, George Gallagher has resigned from the board of Zi Medical with immediate effect. >> Download Word Document
Directors dealings
31/08/2007
The Company was notified today that on 30 August 2007 George Gallagher, a Director of the Company who will resign from the Board of Zi Medical plc subject to the passing of the resolutions at the EGM of the Company to be held on 3 September 2007, sold 2,250,000 ordinary shares of 2p in the Company at a price of 1.68p each. >> Download Word Document
AIM Rule 26 compliance
17/08/2007
The Company announces that information required by AIM Rule 26 (Company Information Disclosure) is available on the Company’s investor relations website.. >> Download Word Document
Disposal of Zimed Limited
17/08/2007
Zi Medical (AIM: ZIM), the medical devices company, announces that it has today sent a circular to shareholders convening an Extraordinary General Meeting of the Company to vote on the Disposal of the Company’s Infusion Business, Zimed Limited (“Zimed”), to Zimed Holdings Limited (“the Disposal”), a company which on completion of the Disposal will be partly owned by George Gallagher, the Company’s current Chief Technical Officer. >> Download Word Document
Proposed disposal of Zimed Limited
17/08/2007
On 26 June 2007, the Company announced that it had entered into heads of agreement to dispose of the Company’s Infusion Business conducted by Zimed. >> Download pdf
Zi Med Change of Registered Address
9/08/2007
Zi Medical (AIM:ZIM), the medical devices company today announces that it has moved registered address to Building 130, Abbott Drive, Kent Science Park, Sittingbourne, Kent ME9 8AZ, United Kingdom. >> Download Word Document
Appointment of Max Dyer Bartlett
13/02/2007
The Board of Zi Medical plc ("Zi Medical"), a leading developer of medical devices, is pleased to announce the appointment of Max Dyer Bartlett, as a Non-Executive Director with immediate effect. >> Link to LSE, RNS Number:1535R
PathScore Development
15/11/2006
Completion of Key PathScore development milestone ahead of commercialisation Appointment of Business Director >> Download pdf
Directorate Appointment
08/08/2006
The Board of Zi-Medical Plc ("Zi Medical"), a leading developer of medical devices, is pleased to announce the appointment of Jacqueline Susan Veness. >> Download pdf
Director Shareholding
03/03/2006
The Company was informed on 30 June 2006 that on that day, Peter Leyland, the Chief Executive Officer of the Company, purchased.... >> Download pdf
Convertible Loan Announcement
30/06/2006
Issue of Convertible Loan Notes, Approval of waiver to be granted by the Panel on Takeovers and Mergers, Notice of Extraordinary General Meeting and Posting of Circular to Shareholders >> Download pdf
Chief Executive Peter Leyland and Chairman Sir Christopher Evans share the view that devices represent the next stage of UK medical development
18/05/2006
After 19 years in the healthcare industry in the UK, the US and Europe with medical giant Baxter Healthcare, Leyland was appointed in April following the resignation of previous CEO Calum McKinlay. He maintains he took the job on the strength of Zis intellectual property portfolio and its relationships with the privatised former MoD laboratory Qinetiq and one of the largest medical devices companies in the world, Cardinal Healthcare. >> Download pdf
The appointment of Alan Edwards as a non-Executive Director
05/05/2006
Fhe Board of Zi Medical pic ("Zi Medical") is pleased to announce the appointment of Alan Edwards, age 58, as a non-Executive Director, with immediate effect. Alan brings to the board a wealth of experience and contacts with over 25 years in the medical devices sector both in the UK & USA. >> Download pdf
The appointment of Peter Anthony Leyland to the position of Chief Executive Officer
19/04/2006
The Board of Zi Medical plc is very pleased to announce the appointment of Peter
Anthony Leyland, an experienced life science professional, to the position of
Chief Executive Officer with immediate effect. Following his MBA Graduate
Studies at Manchester Business School Peter has spent the last 19 years in
healthcare with increasingly responsible and geographically broader roles (UK,
Europe, US & Global) with Travenol Laboratories, Baxter Healthcare (Edwards,
Allegiance, and Renal Divisions) as well as CEO of OrthoRadix Inc. and Cardiak
Limited.
>> Download pdf
Reverse Takeover of Oxford Newtech
29/07/2005
On 8 March 2005, the Company announced that it was in advanced
stage discussions regarding the potential acquisition of the entire issued
share capital of a company funded by a leading European biotechnology
venture capital fund and requested an immediate suspension of trading
in the Existing Shares pending completion of negotiations.
Zi Medical has today agreed conditionally to acquire Oxford Newtech for
a total consideration of £5m, to be satisfied by the issue of 71,878,426
Consideration Shares at 7p per share on Completion. The Company is
also seeking to raise £3.43 million by way of a Placing of 48,970,239
Placing Shares by Brewin Dolphin, at 7p per Ordinary Share.
>> Download pdf
Financial News
Interim and Preliminary Results
VivoMedica plc Director Dealings Announcement 2007
20/12/2007
The Company announces that it received notification today that on 14 December 2007 Mr Peter Leyland, the Chief Executive Officer of the Company, bought 250,000 Ordinary Shares ... >> Download Word Document
VivoMedica plc Director Dealings Announcement 2007
14/12/2007
The Company announces that it received notification yesterday that on 13 December 2007 Ms Susan Veness, the Finance Director of the Company, bought 100,000 Ordinary Shares ... >> Download Word Document
VivoMedica plc Trading Update 2007
08/10/2007
VivoMedica plc (AIM: VVM), the medical devices company, previously Zi Medical Plc, is pleased to provide an update on current trading... >> Download Word Document
Interims release 2007
28/09/2007
I am pleased to be able to report on the interim Results for the six months ended 30 June 2007... >> Download Word Document
Report and Accounts 2006
26/06/2007
I am pleased to be able to report on the performance of Zi Medical for the year ended 31 December 2005, and on major events since the year-end, both in terms of product development and corporate activity... >> Download pdf
Interims Release 2006 Final
04/09/2006
Zi Medical (AIM:ZIM), the medical devices company announces its interim results for the six months ended 30 June 2006. >> Download pdf
Report and Accounts 2005
30/06/2006
I am pleased to be able to report on the performance of Zi Medical for the year ended 31 December 2005, and on major events since the year-end, both in terms of product development and corporate activity... >> Download pdf
Reverse Takeover of Oxford Newtech
29/07/2005
On 8 March 2005, the Company announced that it was in advanced
stage discussions regarding the potential acquisition of the entire issued
share capital of a company funded by a leading European biotechnology
venture capital fund and requested an immediate suspension of trading
in the Existing Shares pending completion of negotiations.
Zi Medical has today agreed conditionally to acquire Oxford Newtech for
a total consideration of £5m, to be satisfied by the issue of 71,878,426
Consideration Shares at 7p per share on Completion. The Company is
also seeking to raise £3.43 million by way of a Placing of 48,970,239
Placing Shares by Brewin Dolphin, at 7p per Ordinary Share.
>> Download pdf